Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

144.74
-2.7600-1.87%
Post-market: 144.910.1700+0.12%19:58 EDT
Volume:5.04M
Turnover:731.35M
Market Cap:179.58B
PE:-55.35
High:148.00
Open:147.65
Low:144.00
Close:147.50
52wk High:157.29
52wk Low:108.46
Shares:1.24B
Float Shares:1.24B
Volume Ratio:0.99
T/O Rate:0.41%
Dividend:3.22
Dividend Rate:2.22%
EPS(TTM):-2.6150
EPS(LYR):6.78
ROE:-20.68%
ROA:14.09%
PB:15.18
PE(LYR):21.35

Loading ...

Gilead - EU Grants Marketing Authorization for Trodelvy with Keytruda in First-Line Pd-L1-Positive Metastatic Tnbc

THOMSON REUTERS
·
Aug 24

European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status

THOMSON REUTERS
·
Aug 24

Funds: What a Top Biotech Fund is Buying Now

Dow Jones
·
Aug 22

Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60

Reuters
·
Aug 22

Moderna Inc. Stock Advances 8.9%, Outperforms Peers

Dow Jones
·
Aug 22

Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit

Reuters
·
Aug 22

Movement Alert|Gilead Sciences Rises 3.07% in Regular Trading, $7.8 Billion Arcellx Acquisition Combined with Q2 Beat Continues to Lift Shares

Market Focus
·
Aug 21

Gilead (GILD) Stock Still Looks Below Fair Value As Court Backs HIV Import Block

Simply Wall St.
·
Aug 21

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 21

Moderna Inc. Stock Slips 23.5%, Underperforms Peers

Dow Jones
·
Aug 21

Moderna Inc. Stock Rallies 177.0%, Outperforms Peers

Dow Jones
·
Aug 20

Movement Alert|Gilead Sciences Rises 3.15% in Regular Trading, $7.8 Billion Arcellx Acquisition Continues to Lift Sentiment

Market Focus
·
Aug 19

What This Top Biotech Fund is Buying Now

Dow Jones
·
Aug 19

Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Disposes of USD 3.86 Million in Common Shares

Reuters
·
Aug 19

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 19

Gilead Sciences Inc Stock (GILD) Moved Up by 3.14% on Aug 18: Drivers Behind the Movement

TradingKey
·
Aug 19

Movement Alert|Gilead Sciences Rises 3.05% in Regular Trading, Announces $7.8 Billion Acquisition of Arcellx to Bolster Oncology Pipeline

Market Focus
·
Aug 18

BMO Capital Reaffirms Their Buy Rating on Gilead Sciences (GILD)

TIPRANKS
·
Aug 18

Gilead Sciences Earnings Call Highlights Strong Core Growth

TIPRANKS
·
Aug 17

Assembly Climbs on Quarterly Revenue Beat

Reuters
·
Aug 14